标题
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2021-12-23
DOI
10.1200/jco.21.02538
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
- (2021) Timothy J. Iveson et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
- (2020) Chao Zhang et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- New Guidelines for optimal patient care with localized colon cancer: recommending what is proven, but also watching what research is bringing.
- (2020) Noelia Tarazona et al. ANNALS OF ONCOLOGY
- Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
- (2020) G. Argiles et al. ANNALS OF ONCOLOGY
- Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer
- (2020) Andreas Teufel et al. EUROPEAN JOURNAL OF CANCER
- Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon
- (2019) Matthew Skancke et al. DISEASES OF THE COLON & RECTUM
- Deficient mismatch repair as a prognostic marker in stage II colon cancer patients
- (2019) Ioannis Gkekas et al. EJSO
- Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer
- (2019) Julie L. Koenig et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline
- (2019) Christopher Lieu et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
- (2019) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal
- (2018) Blake D. Babcock et al. ANNALS OF SURGICAL ONCOLOGY
- A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial
- (2018) Chu Matsuda et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant chemotherapy for stage II colon cancer: who really needs it
- (2018) Yan Yang et al. Cancer Management and Research
- Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
- (2017) Masoud Babaei et al. INTERNATIONAL JOURNAL OF CANCER
- Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
- (2017) Timothy Gilligan et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
- (2017) Alessandro Lugli et al. MODERN PATHOLOGY
- Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer
- (2017) Lin Yang et al. Oncotarget
- To Treat or Not to Treat: Adjuvant Therapy for Stage II Colon Cancer in the Era of Precision Oncology
- (2017) Marios Giannakis et al. Journal of Oncology Practice
- Integration of Palliative Care Into Standard Oncology Care: ASCO Clinical Practice Guideline Update Summary
- (2017) Betty R. Ferrell et al. Journal of Oncology Practice
- Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
- (2016) A C Rogers et al. BRITISH JOURNAL OF CANCER
- Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer
- (2016) Leigh Casadaban et al. CANCER
- Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study
- (2016) Yinzhi Lai et al. GASTROENTEROLOGY
- Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
- (2016) S.R. Verhoeff et al. INTERNATIONAL JOURNAL OF CANCER
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
- (2016) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy
- (2015) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer
- (2014) Aalok Kumar et al. CANCER
- Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
- (2013) Stacie B. Dusetzina et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
- (2012) Christophe Tournigand et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
- (2011) Robin K. Kelley et al. Clinical Colorectal Cancer
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability
- (2011) Richard N Shiffman et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
- (2011) Sonya Blesser Streeter et al. Journal of Oncology Practice
- Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis
- (2010) Gaetan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- Socio-economic disparities in access to treatment and their impact on colorectal cancer survival
- (2010) C. Lejeune et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
- (2009) Neal J. Meropol et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started